Scott J Rodig

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Fundacion Sales, Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet). Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott J Rodig. Retrieved from https://idiyas.com/inventor/scott-j-rodig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

10 out of 1,266

Dana-Farber-Cancer Institute Inc.

Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet)

patents

4. 3 out of 1,425

The Brigham and Women's Hospital, Inc.

The Broad Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11723972 - Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 (2023-08-15),

2. 11673956 - Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1 (2023-06-13),

3. 10948492 - PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers (2021-03-16),

4. 10844126 - Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1 (2020-11-24),

5. 10519238 - Anti-galectin-1 monoclonal antibodies and fragments thereof (2019-12-31),

6. 10456465 - Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 (2019-10-29),

7. 9939428 - Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 (2018-04-10),

8. 9890429 - Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer (2018-02-13),

9. 9206427 - Compositions, kits, and methods for the modulation of immune responses using galectin-1 (2015-12-08),

10. 8968740 - Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 (2015-03-03),

Title: Scott J Rodig - Pioneering Inventor from Westwood, MA

Introduction: Scott J Rodig is a renowned inventor hailing from Westwood, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Scott J Rodig holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Scott J Rodig has worked with top research institutions and companies, consistently pushing the boundaries of what is possible through his inventions.

Collaborations: Throughout his career, Scott J Rodig has collaborated with leading experts in the industry, fostering a culture of innovation and excellence in all his projects.

Conclusion: Scott J Rodig's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a trailblazing inventor in Westwood, MA.

Profile summary based on public USPTO records.